Correlation Between Alkali Metals and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Alkali Metals and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkali Metals and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alkali Metals Limited and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Alkali Metals and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkali Metals with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkali Metals and Emcure Pharmaceuticals.

Diversification Opportunities for Alkali Metals and Emcure Pharmaceuticals

0.46

Correlation Coefficient

Alkali Metals  Emcure Pharmaceuticals

Very weak diversification

The 3 months correlation between Alkali and Emcure is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Alkali Metals Limited and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Alkali Metals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkali Metals Limited are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Alkali Metals i.e., Alkali Metals and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Alkali Metals and Emcure Pharmaceuticals

Assuming the 90 days trading horizon Alkali Metals is expected to generate 4.62 times less return on investment than Emcure Pharmaceuticals. But when comparing it to its historical volatility, Alkali Metals Limited is 1.25 times less risky than Emcure Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  100,800  in Emcure Pharmaceuticals on October 5, 2024 and sell it today you would earn a total of  47,020  from holding Emcure Pharmaceuticals or generate 46.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	27.64%
Values	Daily Returns

Alkali Metals Limited  vs.  Emcure Pharmaceuticals

Alkali Metals Limited

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Alkali Metals Limited are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Alkali Metals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Emcure Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Emcure Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Emcure Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Alkali Metals and Emcure Pharmaceuticals

The main advantage of trading using opposite Alkali Metals and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkali Metals position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Alkali Metals Limited and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.